# Prohibits cost sharing for insulin

**Bill ID:** A4141AA
**Session:** 2023
**Sponsor:** Phara Souffrant Forrest
**Status:** In Assembly Committee

## Summary

Prohibits cost sharing for insulin; provides that an insured shall not be subject to a deductible, copayment, coinsurance or any other cost sharing requirement for the purchase of insulin.

---

## Full Text

S T A T E  O F  N E W  Y O R K
 ________________________________________________________________________
 
  4141--A
 
  2023-2024 Regular Sessions
 
  I N  A S S E M B L Y
 
  February 10, 2023
  ___________
 
 Introduced  by M. of A. FORREST, RAGA, GALLAGHER, SHRESTHA, GONZALEZ-RO-
  JAS, ARDILA, ALVAREZ, DARLING, AUBRY, SIMON, COLTON, BURDICK, MAMDANI,
  CHANDLER-WATERMAN, MITAYNES, MEEKS, STECK, KELLES, BLUMENCRANZ, DeSTE-
  FANO,  WALKER,  SEPTIMO,  TAPIA,  TAYLOR,  THIELE,  ANDERSON,  TAGUE,
  BENDETT, HYNDMAN, DICKENS, DURSO, SIMONE, EPSTEIN, CRUZ, DAVILA, COOK,
  SHIMSKY,  LUNSFORD,  BORES, CURRAN, LEVENBERG, FLOOD, MAHER, JACOBSON,
  BURGOS, HUNTER, CUNNINGHAM, RAJKUMAR, CARROLL, SANTABARBARA,  JACKSON,
  CLARK,  REYES  -- read once and referred to the Committee on Insurance
  -- recommitted to the Committee on Insurance in accordance with Assem-
  bly Rule 3, sec. 2 --  committee  discharged,  bill  amended,  ordered
  reprinted as amended and recommitted to said committee
 
 AN ACT to amend the insurance law, in relation to prohibiting cost shar-
  ing for insulin
 
  THE  PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM-
 BLY, DO ENACT AS FOLLOWS:
 
  Section 1. Subparagraph (B) of paragraph 15-a  of  subsection  (i)  of
 section  3216  of the insurance law, as amended by section 1 of part DDD
 of chapter 56 of the laws of 2020, is amended to read as follows:
  (B) Such coverage may be subject to annual deductibles and coinsurance
 as may be deemed appropriate by the superintendent and as are consistent
 with those  established  for  other  benefits  within  a  given  policy;
 provided  however, [the total amount] that [a covered person is required
 to pay out of pocket for] covered prescription insulin drugs  shall  [be
 capped  at  an  amount  not to exceed one hundred dollars per thirty-day
 supply, regardless of the amount or type of insulin needed to fill  such
 covered  person's  prescription  and regardless of the insured's] NOT BE
 SUBJECT TO A deductible, copayment, coinsurance or any other cost  shar-
 ing requirement.
  ยง 2. Subparagraph (B) of paragraph 7 of subsection (k) of section 3221
 of  the insurance law, as amended by section 2 of part DDD of chapter 56
 of the laws of 2020, is amended to read as follows:
 
  EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
  [ ] is old law to be omitted.
  LBD02649-03-4
 A. 4141--A  2
 
  (B) Such coverage may be subject to annual deductibles and coinsurance
 as may be deemed appropriate by the superintendent and as are consistent
 with those  established  for  other  benefits  within  a  given  policy;
 provided  however, [the total amount] that [a covered person is required
 to  pay  out of pocket for] covered prescription insulin drugs shall [be
 capped at an amount not to exceed one  hundred  dollars  per  thirty-day
 supply,  regardless of the amount or type of insulin needed to fill such
 covered person's prescription and regardless of the  insured's]  NOT  BE
 SUBJECT  TO A deductible, copayment, coinsurance or any other cost shar-
 ing requirement.
  ยง 3. Paragraph 2 of subsection (u) of section 4303  of  the  insurance
 law,  as  amended  by section 3 of part DDD of chapter 56 of the laws of
 2020, is amended to read as follows:
  (2) Such coverage may be subject to annual deductibles and coinsurance
 as may be deemed appropriate by the superintendent and as are consistent
 with those  established  for  other  benefits  within  a  given  policy;
 provided  however, [the total amount] that [a covered person is required
 to pay out of pocket for] covered prescription insulin drugs  shall  [be
 capped  at  an  amount  not to exceed one hundred dollars per thirty-day
 supply, regardless of the amount or type of insulin needed to fill  such
 covered  person's  prescription  and regardless of the insured's] NOT BE
 SUBJECT TO A deductible, copayment, coinsurance or any other cost  shar-
 ing requirement.
  ยง 4. This act shall take effect January 1, 2025 and shall apply to any
 policy  or contract issued, renewed, modified, altered, or amended on or
 after such date.